While the overall risk of JMML in NF1 patients is low, NF1 mutations are implicated in some cases, emphasizing the importance of genomic profiling for treatment decisions, such as hematopoietic cell transplantation. Here, NF1 is linked to juvenile myelomonocytic leukemia.